FDA

New FDA Guidance Tells IVD Makers How to Test for Biotin Interference

On June 13, the FDA issued a draft guidance explaining how makers of in vitro diagnostic devices (IVDs) should perform biotin interference testing and communicate testing results to labs, clinicians … [Read more...]

FOCUS ON

Surviving PAMA: Keep an Eye on Industry Disruptors

A talking point of a G2 Lab Institute 2018 presentation deserves closer attention, especially given its implications for the lab industry. "Advantages and Disadvantages Confronting Labs in a … [Read more...]

EMERGING TESTS

Spectroscopy IDs Potential Metabolic Markers to Diagnose Fibromyalgia

The identification of metabolic patterns in the blood of patients with fibromyalgia may improve diagnosis and enable discovery of targeted treatments, according to a study published Feb. 15 in the … [Read more...]

INDUSTRY BUZZ

Google This: Labs Partner with Tech Giant

In recent months, several diagnostic companies have announced alliances with Google, and all involve Google Cloud Platform. Here is how four companies are using Google's … [Read more...]

NEWS

DNA Testing at the Border

The Department of Homeland Security (DHS) is piloting a DNA testing program at the U.S.-Mexico border. The program aims to establish "DNA-based family relationship (kinship) verification to improve … [Read more...]

FOCUS ON

Genomic Data Sharing: From Utopian Principle to Practical Reality

"Publicly available data should be treated as open data, a shared resource with unrestricted use for analysis, interpretation, and publication." --The journal Science report on genomic data … [Read more...]

CAPITAL

Investment Trends: Dx/Tools Venture Capital Keeps Flowing Despite Decline in Early-Stage Investment

Continuing a four-year trend, total U.S. venture capital investment in health care surged in 2018, reaching a new all-time high of $9.6 billion, according to Silicon Valley Bank's (SVB) Trends in … [Read more...]

NEWS

New Study Finds Lab Automation Market Poised for Continued Growth, Focus on Genomics Solutions

The lab automation market is expected to reach $5.20 billion by 2022 from an estimated $4.06 billion in 2017, at a CAGR rate of 5.1%, according to leading B2B research company MarketsandMarkets. The … [Read more...]

NEWS

Inside the Lab Industry: 5.1% Growth Expected to Lift Lab Automation Market to $5 Billion by 2022

Projected compound annual growth of 5.1% will take the lab automation market from its current $4.06 billion (2017) to $5.20 billion by 2022. The Study This is the finding of a new study on the lab … [Read more...]

TECHNOLOGY

10x Genomics Ordered to Pay $23.9 Million for Infringing Bio-Rad’s Patents

Case: The Federal District Court jury found that 10x willfully infringed three genetic analysis technology patents that Bio-Rad licensed from the University of Chicago on an exclusive basis. … [Read more...]


(-00000g2)